227 related articles for article (PubMed ID: 34023632)
1. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
3. Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis.
Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S
Muscle Nerve; 2023 Jan; 67(1):17-24. PubMed ID: 36214183
[TBL] [Abstract][Full Text] [Related]
4. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
He R; Zheng M; Lian L; Yao X
Cells; 2021 May; 10(5):. PubMed ID: 34067647
[TBL] [Abstract][Full Text] [Related]
5. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
6. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.
Ackrivo J; Hansen-Flaschen J; Jones BL; Wileyto EP; Schwab RJ; Elman L; Kawut SM
Am J Respir Crit Care Med; 2019 Dec; 200(12):1513-1521. PubMed ID: 31322417
[No Abstract] [Full Text] [Related]
7. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
[TBL] [Abstract][Full Text] [Related]
8. Prolonged distal latency of the median motor nerve is associated with poor prognosis in amyotrophic lateral sclerosis.
Sato M; Nakamura T; Nagashima K; Fujita Y; Ikeda Y
Neurol Res; 2021 Mar; 43(3):191-198. PubMed ID: 33054692
[TBL] [Abstract][Full Text] [Related]
9. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
[TBL] [Abstract][Full Text] [Related]
10. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Chiò A; Andrews JA; Genge A; Jackson CE; Lechtzin N; Miller TM; Shefner JM
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):304-310. PubMed ID: 36503310
[TBL] [Abstract][Full Text] [Related]
11. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
Ludolph AC; Corcia P; Desnuelle C; Heiman-Patterson T; Mora JS; Mansfield CD; Couratier P
Muscle Nerve; 2024 Jul; 70(1):36-41. PubMed ID: 38712849
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.
Luna J; Couratier P; Lahmadi S; Lautrette G; Fontana A; Tortelli R; Logroscino G; Preux PM; Copetti M; Benoit M
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):478-485. PubMed ID: 33829938
[No Abstract] [Full Text] [Related]
13. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
14. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
15. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis.
Colombo E; Doretti A; Scheveger F; Maranzano A; Pata G; Gagliardi D; Meneri M; Messina S; Verde F; Morelli C; Corti S; Maderna L; Silani V; Ticozzi N
J Neurol; 2023 Jan; 270(1):511-518. PubMed ID: 36183286
[TBL] [Abstract][Full Text] [Related]
16. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
17. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study.
Kjældgaard AL; Pilely K; Olsen KS; Jessen AH; Lauritsen AØ; Pedersen SW; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Elmo EG; Møller AT; Bonefeld L; Berg M; Garred P; Møller K
BMC Neurol; 2021 Apr; 21(1):164. PubMed ID: 33865343
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the King's and MiToS staging systems for ALS.
Fang T; Al Khleifat A; Stahl DR; Lazo La Torre C; Murphy C; ; Young C; Shaw PJ; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):227-232. PubMed ID: 28054828
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
[TBL] [Abstract][Full Text] [Related]
20. Rate of disease progression: a prognostic biomarker in ALS.
Labra J; Menon P; Byth K; Morrison S; Vucic S
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
